The global ECG equipment and management systems market size is evaluated at USD 8.22 billion in 2025 and is forecasted to hit around USD 13.97 billion by 2034, growing at a CAGR of 6.07% from 2025 to 2034. The North America market size was accounted at USD 3.64 billion in 2024 and is expanding at a CAGR of 6.10% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: ECG Equipment and Management Systems Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. ECG Equipment and Management Systems Market Revenue and Volume, By Type
8.1.1 Holter Monitors
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Resting ECG system
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Stress ECG Monitors
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Event Monitoring Systems
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. ECG Management Systems
8.1.5.1. Market Revenue and Volume Forecast
9.1. ECG Equipment and Management Systems Market Revenue and Volume, By End-use
9.1.1. Hospitals & Clinics
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Ambulatory Facilities
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Type
10.1.2. Market Revenue and Volume Forecast, By End-use
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Type
10.1.3.2. Market Revenue and Volume Forecast, By End-use
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Type
10.1.4.2. Market Revenue and Volume Forecast, By End-use
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Type
10.2.2. Market Revenue and Volume Forecast, By End-use
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Type
10.2.3.2. Market Revenue and Volume Forecast, By End-use
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Type
10.2.4.2. Market Revenue and Volume Forecast, By End-use
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Type
10.2.5.2. Market Revenue and Volume Forecast, By End-use
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Type
10.2.6.2. Market Revenue and Volume Forecast, By End-use
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Type
10.3.2. Market Revenue and Volume Forecast, By End-use
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Type
10.3.3.2. Market Revenue and Volume Forecast, By End-use
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Type
10.3.4.2. Market Revenue and Volume Forecast, By End-use
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Type
10.3.5.2. Market Revenue and Volume Forecast, By End-use
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Type
10.3.6.2. Market Revenue and Volume Forecast, By End-use
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Type
10.4.2. Market Revenue and Volume Forecast, By End-use
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Type
10.4.3.2. Market Revenue and Volume Forecast, By End-use
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Type
10.4.4.2. Market Revenue and Volume Forecast, By End-use
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Type
10.4.5.2. Market Revenue and Volume Forecast, By End-use
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Type
10.4.6.2. Market Revenue and Volume Forecast, By End-use
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Type
10.5.2. Market Revenue and Volume Forecast, By End-use
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Type
10.5.3.2. Market Revenue and Volume Forecast, By End-use
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Type
10.5.4.2. Market Revenue and Volume Forecast, By End-use
11.1. Compumed Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Biotelemetry Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. GE Healthcare
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Mindray Medical.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Hill Rom.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Philips Healthcare
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Schiller AG.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Spacelabs Healthcare
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample